Patel Snehal 4

What Happened
Snehal Patel, reported as a 10% owner of Greenwich LifeSciences (GLSI), made two purchases of company stock: 2,500 shares on 2026-07-23 at $13.14 ($32,850) and 1,100 shares on 2026-07-24 at $12.88 ($14,168), for a combined 3,600 shares purchased for $47,018. These were reported as purchases (transaction code P), which are typically viewed by investors as a bullish signal since the insider added to their stake.

Key Details

• Transaction dates and prices: 2026-07-23 — 2,500 shares @ $13.14 ($32,850); 2026-07-24 — 1,100 shares @ $12.88 ($14,168).
• Total purchased: 3,600 shares for $47,018.
• Transaction type: Purchase (P) — open market or private purchase as reported.
• Shares owned after transaction: Not specified in the filing excerpt provided.
• Filing date: Form 4 filed 2026-07-27 covering trades on 2026-07-23 and 07-24. Form 4s are generally due within two business days of the transaction, so this filing may appear delayed — check the full filing for any late-filing notation.
• No footnotes reported in the provided excerpt (e.g., no 10b5-1 plan or tax-withholding notes shown).

Context
As a 10% owner (as reported), Snehal Patel is a significant shareholder; this classification differs from executive or director trading but is still disclosed under Section 16 rules. Purchases by insiders can be more informative than sales, but they do not guarantee future stock performance. For full details (exact post-transaction holdings, any footnotes, or late-filing explanations) consult the complete Form 4 filing (Accession: 0001493152-26-034675).